Millions of people are victims of rare diseases across the globe. The opportunities and threats that each condition present to a small patient group will add up to a significant societal health issue. To drug developers, the science is complicated, recruiting patients is laborious, and it is costly. To fill this loophole, the US FDA established the orphan drug designation program. In case you...
What’s Fueling Executive Summary Central Precocious Puberty (CPP) Treatment Market Size and Share Growth
CAGR Value
Global central precocious puberty (CPP) treatment market size was valued at USD 1.84 billion in 2024 and is projected to reach USD 3.31 billion by 2032, with a CAGR of 7.60% during the forecast period of 2025 to 2032.
An influential Central Precocious Puberty (CPP)...
Executive Summary Autoimmune Gastrointestinal Dysmotility Market Size and Share Forecast
CAGR Value
The global autoimmune gastrointestinal dysmotility market size was valued at USD 39.45 billion in 2024 and is expected to reach USD 155.47 billion by 2032, at a CAGR of 18.70% during the forecast period
Complex market insights are represented in a simpler version in the world class...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek